Advertisement
Advertisement
ACRV
Acrivon Therapeutics, Inc. Common Stock
1.62
USDSponsored
-0.01
-0.61%
Jun 24, 15:11 UTC -4
Closed
After-Market
1.61
-0.01
-0.31%
ACRV Earnings Reports
Positive Surprise Ratio
ACRV beat 11 of 14 last estimates.
79%
Next Report
Date of Next Report
Aug 11, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/-$0.51
Implied change from Q1 26 (Revenue/ EPS)
--
/+4.08%
Implied change from Q2 25 (Revenue/ EPS)
--
/-7.27%
Acrivon Therapeutics, Inc. Common Stock earnings per share and revenue
On May 13, 2026, ACRV reported earnings of -0.49 USD per share (EPS) for Q1 26, beating the estimate of -0.53 USD, resulting in a 8.57% surprise. Revenue reached --, compared to an expected 282.20 thousand, with a -100.00% difference. The market reacted with a 0.00% price change (close before vs. close after earnings).
Looking ahead to Q2 26, -- analysts forecast an EPS of -0.51 USD, with revenue projected to reach -- USD, implying an increase of 4.08% EPS, and increase of 0.00% in Revenue from the last quarter.
FAQ
What were Acrivon Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Acrivon Therapeutics, Inc. Common Stock reported EPS of -$0.49, beating estimates by 8.57%, and revenue of $0.00, -100% below expectations.
How did the market react to Acrivon Therapeutics, Inc. Common Stock's Q1 2026 earnings?
The stock price moved -- 0%, changed from $1.92 before the earnings release to $1.92 the day after.
When is Acrivon Therapeutics, Inc. Common Stock expected to report next?
The next earning report is scheduled for Aug 11, 2026.
What are the forecasts for Acrivon Therapeutics, Inc. Common Stock's next earnings report?
Based on --
analysts, Acrivon Therapeutics, Inc. Common Stock is expected to report EPS of -$0.51 and revenue of -- for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement